Hope for Huntington's Disease

The Faculty of 1000 is a Web-based literature awareness tool published by BioMed Central. It provides a continuously updated insider's guide to the most important papers within a range of research fields, based on the recommendations of a faculty of over 1,400 leading researchers. Each issue, The Scientist will publish a list of the 10 top-rated papers from a specific subject area, as well as a short review of one or more of the listed papers. We will also publish a selection of comments on inte

Douglas Steinberg
Jan 20, 2002
The Faculty of 1000 is a Web-based literature awareness tool published by BioMed Central. It provides a continuously updated insider's guide to the most important papers within a range of research fields, based on the recommendations of a faculty of over 1,400 leading researchers.

Each issue, The Scientist will publish a list of the 10 top-rated papers from a specific subject area, as well as a short review of one or more of the listed papers. We will also publish a selection of comments on interesting recent papers from the Faculty of 1000's output. For more information visit www.facultyof1000.com.




For the first time, a study is suggesting a viable treatment to stop and even reverse Huntington's disease (HD), a lethal disorder afflicting about one of every 15,000 people. This treatment involves a class of drugs already being tested on cancer patients.



F1000 Top 10 Neuroscience

1. Y. Zhou et...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?